Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are relatively new medications for diabetes that offer a weight-loss profile that can be considered desirable for patients with both type 2 diabetes (T2D) and obesity. GLP-1 RA are effective in combination with insulin, and even slightly superior or at least equal to short-acting insulin in T2D; however, since they work in the incretin system, they may not be effective in long-standing disease. Additionally, only recently have publications reported their cardiovascular safety, and there is limited evidence for long-term effectiveness. The work presented by Huetson et al. offers a much needed perspective through a medical economic model for the long term cost-effectiveness of GLP-1 RA. The authors found benefits in quality-adjusted life years and reduced lifetime healthcare costs. While there are a few limitations, this study contributes to the understanding of these agents and their impact on the epidemics of obesity in T2D, where weight management is no longer an option, but an essential component of the diabetes plan of care.
References
Sep 5, 2008·PharmacoEconomics·Christopher McCabeAnthony J Culyer
Nov 17, 2009·Journal of Diabetes and Its Complications·Holly KramerRamon Durazo-Arvizu
Feb 23, 2010·Diabetes Research and Clinical Practice·Ping ZhangGregory Nichols
Oct 19, 2011·Journal of General Internal Medicine·Quyen Ngo-MetzgerSherrie H Kaplan
May 1, 2013·Diabetes Care·Matthew C RiddleJulio Rosenstock
Dec 21, 2013·PharmacoEconomics·Carl V AscheDean T Eurich
Jul 12, 2014·Diabetes Care·Michaela DiamantUNKNOWN 4B Study Group
Jul 31, 2014·Diabetes, Obesity & Metabolism·W M Valencia, H Florez
Sep 4, 2014·Current Diabetes Reports·Willy Marcos ValenciaHermes Florez
Sep 16, 2014·Lancet·Conrad EngRavi Retnakaran
Oct 6, 2014·The American Journal of Medicine·Steven Edelman, Jeremy Pettus
Dec 30, 2014·Diabetes Care·Silvio E InzucchiDavid R Matthews
Mar 22, 2015·Journal of Diabetes and Its Complications·Yeganeh Manon KhazraiPaolo Pozzilli
Apr 9, 2015·Journal of Medical Economics·Pernilla HuetsonEuan McLeod
Apr 11, 2015·Clinical Medicine Insights. Endocrinology and Diabetes·Andreas LieblJean-Francois Yale
Apr 17, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberMichael H Davidson
May 23, 2015·Diabetes Care·Luc Van Gaal, André Scheen
Jun 10, 2015·Journal of Medical Economics·W SuL Perreault